Viva Biotech Holdings (VB0) — Financial Flexibility Index
Viva Biotech Holdings (VB0) has a Financial Flexibility Index of 0.05x as of June 2023. Free cash flow of €209.53 Million (operating CF €158.72 Million minus capex €50.80 Million) represents 0% of total liabilities (€4.51 Billion). Check VB0 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Viva Biotech Holdings Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Viva Biotech Holdings across 9 annual periods. For the full cash flow conversion analysis, see Viva Biotech Holdings cash conversion from operations.
Annual Financial Flexibility Index for Viva Biotech Holdings (2016–2024)
Year-by-year free cash flow to debt coverage for Viva Biotech Holdings. Explore cash flow to debt ratio of Viva Biotech Holdings to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.17x | €565.66 Million | €373.99 Million | €3.23 Billion | ▲ +15.2% |
| 2023 | 0.15x | €571.24 Million | €383.40 Million | €3.76 Billion | ▲ +3.1% |
| 2022 | 0.15x | €635.38 Million | €386.05 Million | €4.32 Billion | ▼ -5.4% |
| 2021 | 0.16x | €643.01 Million | €77.83 Million | €4.13 Billion | ▲ +7.6% |
| 2020 | 0.14x | €635.80 Million | €43.18 Million | €4.40 Billion | ▼ -82.8% |
| 2019 | 0.84x | €102.20 Million | €46.01 Million | €121.39 Million | ▲ +296.5% |
| 2018 | 0.21x | €59.01 Million | €12.11 Million | €277.90 Million | ▼ -77.5% |
| 2017 | 0.94x | €46.81 Million | €27.89 Million | €49.64 Million | ▼ -16.1% |
| 2016 | 1.12x | €28.46 Million | €21.12 Million | €25.32 Million | — |